Epidemic of Mucormycosis in COVID-19 Pandemic: A Position Paper
- PMID: 35342268
- PMCID: PMC8954338
- DOI: 10.4103/aian.AIAN_421_21
Epidemic of Mucormycosis in COVID-19 Pandemic: A Position Paper
Abstract
During the second wave of COVID-19 pandemic, there is a sudden increase in number of cases mucormycosis infection in India. This communication by the Tropical Neurology subsection expert group of the Indian Academy of Neurology (IAN) describes the clinical and diagnostic features, treatment of the disease and gives recommendations about the ways forward.
Keywords: COVID-19; Mucormycosis; rhino-orbito-cerebral syndrome.
Copyright: © 2006 - 2021 Annals of Indian Academy of Neurology.
Conflict of interest statement
There are no conflicts of interest.
Figures
References
-
- Patel A, Kaur H, Xess I, Michael JS, Savio J, Rudramurthy S, et al. A multicenter observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India. Clin Microbiol Infect. 2020;26:944.e9–944.e15. - PubMed
-
- WHO. coronavirus (COVID-19) dashboard
